Pravin T. P. Kaumaya Department of Obstetrics & Gynecology The Ohio State University Wexner Medical Center Biography Publications Institution JoVE Articles Pravin T. P. Kaumaya has not added a biography. If you are Pravin T. P. Kaumaya and would like to personalize this page please email our Author Liaison for assistance. Publications Therapeutic Cancer Vaccines for the Management of Recurrent and Metastatic Head and Neck Cancer: A Review JAMA Otolaryngology-- Head & Neck Surgery. Feb, 2023 | Pubmed ID: 36580281 A Newly Discovered PD-L1 B-cell Epitope Peptide Vaccine (PDL1-Vaxx) Exhibits Potent Immune Responses and Effective Anti-tumor Immunity in Multiple Syngeneic Mice Models and (synergizes) in Combination with a Dual HER-2 B-cell Vaccine (B-Vaxx) Oncoimmunology. 2022 | Pubmed ID: 36211807 Preclinical Studies of a Novel Human PD-1 B-Cell Peptide Cancer Vaccine PD1-Vaxx From BALB/c Mice to Beagle Dogs and to Non-Human Primates (Cynomolgus Monkeys) Frontiers in Oncology. 2022 | Pubmed ID: 35646678 First Prototype Checkpoint Inhibitor B-cell Epitope Vaccine (PD1-Vaxx) En Route to Human Phase 1 Clinical Trial in Australia and USA: Exploiting Future Novel Synergistic Vaccine Combinations British Journal of Cancer. Jul, 2021 | Pubmed ID: 33772155 Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jun, 2019 | Pubmed ID: 30804020 Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC) Vaccines. Jul, 2015 | Pubmed ID: 26350593 A Paradigm Shift: Cancer Therapy with Peptide-based B-cell Epitopes and Peptide Immunotherapeutics Targeting Multiple Solid Tumor Types: Emerging Concepts and Validation of Combination Immunotherapy Human Vaccines & Immunotherapeutics. 2015 | Pubmed ID: 25874884 Bridging Oncology and Immunology: Expanding Horizons with Innovative Peptide Vaccines and Peptidomimetics Immunotherapy. Nov, 2013 | Pubmed ID: 24188668 Immunotherapy with HER-2 and VEGF Peptide Mimics Plus Metronomic Paclitaxel Causes Superior Antineoplastic Effects in Transplantable and Transgenic Mouse Models of Human Breast Cancer Oncoimmunology. Oct, 2012 | Pubmed ID: 23170249 Peptide Vaccines and Targeting HER and VEGF Proteins May Offer a Potentially New Paradigm in Cancer Immunotherapy Future Oncology (London, England). Aug, 2012 | Pubmed ID: 22894670 Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction (Video) | JoVE Jay Overholser*1, Linlin Guo*1, Pravin T. P. Kaumaya1,2 1Department of Obstetrics & Gynecology, The Ohio State University Wexner Medical Center, 2The James Comprehensive Cancer Center JoVE 65467 Cancer Research
Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction (Video) | JoVE Jay Overholser*1, Linlin Guo*1, Pravin T. P. Kaumaya1,2 1Department of Obstetrics & Gynecology, The Ohio State University Wexner Medical Center, 2The James Comprehensive Cancer Center JoVE 65467 Cancer Research
